Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalLEUKEMIA & LYMPHOMA
DOIs
Publication statusPublished - 2016

Keywords

  • hepatitis b
  • myeloid leukemia

Fingerprint

Dive into the research topics of 'Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Cite this